About Us

Vision

To design molecules to fuel human progress

Mission

To use AI-driven molecules design to enable rapid, reliable discovery of ever more effective drugs

At MOLCURE, we believe that best molecular designs emerge from combining AI with large, high-quality experimental datasets. We accelerate drug discovery through close collaboration with pharmaceutical partners, leveraging our multidisciplinary team of machine learning scientists, biochemists, and bioinformaticians. With over 11 years of experience, we have been dedicated to generating extensive datasets and developing advanced AI models to deliver innovative solutions for the future of medicine.

Team

tamakisan_maru

Satoshi Tamaki, Ph.D.
CEO / CSO

Ph.D. in Media and Governance from Keio University. Specializes in large-scale sequence analysis of DNA and proteins using bioinformatics. Former postdoctoral fellow at Japan Society for the Promotion of Science (JSPS). Over 20 years of experience in bioinformatics and 15 years in AI.

ogawasan_maru

Ryu Ogawa, Ph.D.
CIO / Founder

Ph.D. from Keio University. Developed AI-based methods for predicting DNA-protein complex formation while leading an epigenetics research team at Keio University’s Institute for Advanced Biosciences. Founded MOLCURE in 2013. Has over 20 years of experience in AI and a long-standing passion for programming, winning multiple coding competitions from an early age.

negishisan_maru

Natsumi Negishi
CFO

B.A. from University of Tokyo. Former securities analyst at Nomura Securities and Daiwa Securities. Later joined STRIVE as venture capital partner, supporting startups in AI and biotech. Joined MOLCURE in 2021. Brings extensive expertise in finance and startup development.

sergee-maru

Batsergelen Myagmar, Ph.D.
CAIO

Ph.D. in Engineering from University of Tsukuba. Over 10 years of experience in AI, with a focus on deep learning and large language models. More than 20 years of experience in software development. Built MOLCURE’s AI model library and antibody data analysis framework.

han

Han Lim, Ph.D., MBBS
Senior Advisor

Current CBO at DeepCure, and former CBO at Atomwise Inc., faculty at University of California, Berkeley and researcher at MIT. Accomplished business leader and R&D planning in AI drug discovery.

takahashisan_maru

Koichi Takahashi, Ph.D.
Senior Advisor

Current principal investigator at RIKEN Institute, director at The Whole Brain Architecture Initiative and professor at Keio University and Osaka University. An advocate and a leader for AI-driven sciences field.

miurasan_maru

Kengo Miura
External director

Joined JAFCO in 2015, focusing on R&D startup investments within Academia-Industry Collaboration and Life Sciences Group. Involved in government programs, incl. JST START and IPAS. Graduated from Grad. School of Bioscience/tech at Tokyo Institute of Technology.

tsutsumi-san

Tatsuo Tsutsumi
External director

Founded GREE Ventures and became General Partner of a new VC fund. Directed new business development and establishment of CVC arms at CyberAgent, Recruit, and GREE. Previously worked at Sanwa Research Institute and Global Brain.

abesan_maru

Hiroshi Abe
Statutory auditor

Began career at Suntory in 2000, engaging in sales for the food and beverage sector. Later joined Deloitte Touche Tohmatsu, handling audit, IPO support, and consulting services. Moved to Accounting Force Tax Accountant Corporation in 2015. Serving as MOLCURE’s outside auditor since 2019. Has over 20 years of experience in finance and auditing.